Cytokinetics | CYTK - Ebitda


Cytokinetics reported $-169.32M in EBITDA for its fiscal quarter ending in March of 2026.





Ebitda Change Date
Acadia Pharmaceuticals USD -1.62M 21.94M Mar/2026
Amgen USD 3.86B 1.28B Mar/2026
Arca Biopharma USD -25.07M 5.23M Mar/2025
Bayer EUR 2.14B 2.31B Jun/2026
Biogen USD 649.7M 76.5M Mar/2026
Brainstorm Cell Therapeutics USD -3.04M 99K Mar/2025
Bristol-Myers Squibb USD 4.24B 1.37B Mar/2026
Capricor Therapeutics USD -27.23M 2.66M Jun/2025
Cytokinetics USD -169.32M 19.48M Mar/2026
Eisai JPY 34.15B 34.48B Jun/2026
Eli Lilly USD 10.29B 1.86B Mar/2026
Exelixis USD 255.4M 2.89M Jun/2026
Geron USD 3.83M 25.12M Mar/2026
Halozyme Therapeutics USD 328.81M 109.24M Jun/2026
Ionis Pharmaceuticals USD -64.53M 135.49M Mar/2026
Ligand Pharmaceuticals USD -14.3M 81.08M Mar/2026
Merck USD -1.54B 7.84B Mar/2026
Novartis USD 6.48B 1.19B Jun/2026
Pfizer USD 6.01B 18M Jun/2026
Regeneron Pharmaceuticals USD 1.66B 695.2M Jun/2026
Roche Holding CHF 13.43B 744M Jun/2026
Sanofi EUR 3.69B 375M Jun/2026